Artios signs research collaboration with MU to develop novel cancer treatments

12 Jun 2017

Artios _logoCambridge, UK, 12 June 2017. Artios Pharma Ltd., a leading DNA Damage Response (DDR) company developing innovative new treatments for cancer, today announces it has signed a research collaboration and option agreement with Masaryk University MU in the Czech Republic for the development of novel cancer treatments targeting DNA nucleases involved in the DDR.

Read the whole press release here.

 


More articles

All articles

You are running an old browser version. We recommend updating your browser to its latest version.

More info